$9,687+ yesterday trading the secrets of Wall Street’s deepest pockets…
You may remember my highest conviction trade idea from yesterday…
It became my single best bread-winner, and it took under 30 minutes to achieve that stature.
Today I’ve got my eyes on a stock which professionals managing $1B+ assets under management may be trading as soon as this morning…
I believe it could provide another juicy payday, and I want to guide you through exactly why I like it at this very moment.
In the new world in which we live, there is no shortage of medical professionals insisting on an effective vaccine that prevents the spread of COVID-19 being available to the public prior to fully reopening economies and lifting social distancing mandates.
We’re still waiting for an approved treatment, and while it is unclear exactly when it will arrive, many pharmaceutical companies are working diligently to produce, test, and offer an effective vaccine for preventing the spread of COVID-19.
The latest pharmaceutical company to give themselves an edge in this arena is Novavax Inc (NYSE: NVAX). Recently, NVAX announced a partnership with ABC Biologics.
This new collaboration is designed to expedite the production and testing of vaccine components, and this new partnership catalyst may produce a lift NVAX’s positive sentiment within the pharmaceutical world, which is primarily dominated by companies such as Gilead and Pfizer.
Now the question “when will NVAX have a vaccine available to be tested?” may be asked more frequently. While we don’t know the answer to that question, I do know that NVAX trades on fairly light options volume.
What this means is that if I see the slightest hint of unusual options activity sweeps hit the tape on NVAX – some “insider” might know something ahead of time!
Identifying unusual options activity moves related to a COVID-19 vaccine (which costs me quite a bit of money to monitor) is exactly how I was able to inform you of the potential of Gilead’s and INO’s vaccines being ready to test, before their surges in price per share happened.
After having made 700% on Gilead and 120% on INO in less than 24 hours responding to unusual options activity with a vaccine as my catalyst, I’ll be looking over the shoulder of Wall Street’s biggest option players today in an attempt to do the same with NVAX.
Yours for TrackStar trading,
America’s #1 Premarket and Day Trader
Disclaimer: This is not investment advice. This article is for information purposes only and opinion-based on financial advisor data across a selection of websites. Investors should be cautious about any and all investments and are advised to conduct their own due diligence prior to making any investment decisions.